Sign in
4

Changes in Ownership

Altimmune, Inc. Filed Acc 0000925421-19-000135

Options or other derivatives

  • Chief Scientific Officer acquired 38,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Roberts M Scot · Chief Scientific Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-03-26 Grant or award : show line 1 in the form Stock Options (option to buy) +38,000 38,000 D
Loading xslF345X03/edgar.xml…